PL04a.02: OAK, a Randomized Ph III Study of Atezolizumab vs Docetaxel in Patients with Advanced NSCLC: Results from Subgroup Analyses
暂无分享，去创建一个
Keunchil Park | D. Gandara | F. Ciardiello | C. Barrios | C. Matheny | S. Gadgeel | F. Barlesi | Daniel S Chen | M. Ballinger | A. Sandler | M. Kowanetz | T. Hida | J. Leach | D. Kowalski | D. Cortinovis | J. Pawel | Daniel S. Chen | A. Rittmeyer | D. Waterkamp | P. He | M. C. Dols | J. Polikoff